731 filings
Page 30 of 37
8-K
j1ogst
6 May 09
Acorda Therapeutics Announces FDA Acceptance of Fampridine-SR
12:00am
8-K
x6k5f4y3y ktdk
6 May 09
Results of Operations and Financial Condition
12:00am
8-K
kjya1 8u5
30 Apr 09
Other Events
12:00am
DEFA14A
dqufoq rm
30 Apr 09
Additional proxy soliciting materials
12:00am
8-K
45vgug
23 Apr 09
Acorda Therapeutics Resubmits New Drug Application for Fampridine-SR for Improvement of Walking Ability in People with Multiple Sclerosis
12:00am
8-K
yku3sn4jml
31 Mar 09
Acorda Therapeutics Receives Refuse to File Letter from FDA
12:00am
S-8
l8e70
18 Mar 09
Registration of securities for employees
12:00am
8-K
sck3m maxiqla
24 Feb 09
Results of Operations and Financial Condition
12:00am
8-K
rqcwd
13 Feb 09
Departure of Directors or Certain Officers
12:00am
8-K
48k4i hg8ok8n5zjbd
2 Feb 09
Acorda Therapeutics Submits New Drug Application for Fampridine-SR for Improvement of Walking Ability in People with Multiple Sclerosis
12:00am
8-K
cf6846ejnka
12 Jan 09
Other Events
12:00am
8-K
byevch
1 Dec 08
Acorda Therapeutics Elects John P. Kelley to Board of Directors
12:00am
8-K
d4c7hy3pubj3
4 Nov 08
Results of Operations and Financial Condition
12:00am
8-K
121y5wzggy8 b9nu4
19 Aug 08
Acorda Therapeutics, Inc. Announces Exercise of Option by Underwriter
12:00am
8-K
3p3il3ey6
7 Aug 08
Acorda Therapeutics, Inc. Announces Pricing of Common Stock Offering
12:00am
424B5
u7kgc
7 Aug 08
Prospectus supplement for primary offering
12:00am